← All trials
NCT00235183
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2005
- Primary completion
- Dec 31, 2009
- Completion date
- Dec 31, 2010
- First posted
- Oct 10, 2005
- Last posted
- Feb 17, 2014
- Enrollment
- 300
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Etablissement Français du SangLead sponsor
- Institut CochinOverall official - principal investigator
- Institut CochinOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.